Hyperammonemia following allogeneic bone marrow transplantation

  title={Hyperammonemia following allogeneic bone marrow transplantation},
  author={Nielson Tse and Stephen D Cederbaum and John A. Glaspy},
  journal={American Journal of Hematology},
Hyperammonemia is a rare and serious complication of intensive cytotoxic chemotherapy. We report the case of a patient who developed profound idiopathic hyperammonemia following bone marrow transplantation for chronic myelogenous leukemia. Despite rapid institution of hemodialysis, sodium benzoate, and the experimental agent sodium phenylacetate, the patient ultimately succumbed to complications of this metabolic derangement. The literature is reviewed, and recommendations for an approach to… Expand
Hyperammonemia after high-dose chemotherapy and stem cell transplantation
A patient with multiple myeloma who suffered from hyperammonemia after a second stem cell autograft is reported, with rapid recognition and treatment of the syndrome, the patient fully recovered. Expand
Idiopathic hyperammonaemia syndrome following allogeneic peripheral blood progenitor cell transplantation (allo-PBPCT)
An idiopathic hyperammonaemia syndrome has been reported in, and following chemotherapy for, various haematological malignancies as well as following bone marrow transplantation, and a further case associated with an allogeneic peripheral blood progenitor cell transplant is described. Expand
Transient Hyperammonemic Encephalopathy in a Child with Relapsed Acute Lymphoblastic Leukemia and Severe Tumor Lysis Syndrome
Idiopathic hyperammonemia (IHA) is a severe condition, which has been reported in intensive chemotherapy and bone marrow transplantation. This case elucidates the diagnostic dilemma in childrenExpand
Hyperammonemia encephalopathy: An important cause of neurological deterioration following chemotherapy
Optimal management remains to be formally established, and the critical step is increased awareness of the syndrome by measurement of plasma ammonium levels in patients with neurological symptoms, leading to early diagnosis and the prompt implementation of therapy. Expand
Hyperammonemia Syndrome After Lung Transplantation: A Single Center Experience
The largest case series to date of hyperammonemia after lung transplantation (LTx) is presented and a treatment protocol is discussed that has been developed at an institution and future research is needed to determine the efficacy of treatment. Expand
Neurologic complications of bone marrow transplantation.
The various forms of HSCT are or will soon be accepted treatments for an ever-increasing number of hematologic and solid cancers. Attempts to reduce the mortality and morbidity of HSCT and at theExpand
Hyperammonemic encephalopathy after chemotherapy. Survival after treatment with sodium benzoate and sodium phenylacetate.
A 16-year-old boy had hyperammonemia and encephalopathy develop after high-dose chemotherapy for acute lymphoblastic leukemia. He was treated successfully with the ammonia-trapping agents sodiumExpand
Neurological Complications of Hematopoietic Stem Cell Transplantation
This chapter summarizes the disorders affecting the nervous system associated with hematopoietic stem cell transplantation. Expand
Neurologic Complications of Hematopoietic Stem Cell Transplantation
HSCT is now a common procedure to treat hematologic malignant disorders thought to be largely incurable and has potential use for a number of solid neoplasms and non-neoplastic disorders. Expand
Idiopathic hyperammonemia in a patient with total pancreatectomy and islet cell transplantation.
It is proposed that malnutrition following total pancreatectomy resulting in repressed urea cycle enzyme synthesis may have predisposed for this hyperammonemia. Expand


Syndrome of idiopathic hyperammonemia after high-dose chemotherapy: review of nine cases.
Because neurologic function can deteriorate rapidly, early recognition of this disorder and close monitoring of the patient's neurologic status are critical. Expand
Reye's syndrome: Current concepts
What factors (NH3, free fatty acids and dicarboxylic acids) may be implicated in the pathogenesis of the CNS disease with the hopes of devising strategies for more effective treatment of encephalopathy and its attendant morbidity and mortality should be delineated. Expand
Automated enzymatic assay for plasma ammonia.
An enzymatic method for determining plasma ammonia with the Du Pont Automatic Clinical Analyzer (aca) is described, using the coenzyme NADPH (instead of NADH) in this aca procedure eliminates the lengthy pre-incubation otherwise required for endogenous dehydrogenase reactions. Expand